I am a board-certified urologic surgeon who specializes in surgery for patients with genitourinary cancers. My expertise is in the clinical care and surgical treatment of patients with testicular cancer. I work closely with colleagues from medical oncology, pathology, radiology, and radiation therapy to provide the most effective treatment for our patients, as well as to establish the optimal multidisciplinary approach for all patients with testicular cancer.
I have developed surgical techniques to preserve patients’ fertility through the use of “nerve sparing” retroperitoneal lymph node dissection (RPLND). This approach is appropriate for most patients who have low-stage disease and for many patients with more-advanced cancers who have completed treatment with chemotherapy. For the past decade I have performed approximately 100 RPLNDs per year. Because of my particular expertise in retroperitoneal surgery, I also work with specialists in other disciplines to surgically manage different types of tumors in the retroperitoneum.
I have written numerous articles and book chapters on testicular cancer care and frequently speak on the topic at national and international forums. As an established leader in testicular cancer I have edited special editions on this disease in Urologic Clinics of North America, the World Journal of Urology, the British Journal of Urology, Urologic Oncology, and Seminars in Urologic Oncology. Furthermore, I have written or co-authored the chapter on the surgical management of testicular cancer for the major textbooks in urology (Campbell’s Urology, 8th, 9th, and 10th editions) and oncology (DeVita’s Principles and Practice of Oncology, 5th, 6th, 7th, 8th, and 9th editions).
I serve as faculty director for the course on testicular cancer for the American Urological Association and am a member of the National Comprehensive Cancer Network’s guidelines committee for testicular cancer and kidney cancer.
I am an associate editor of Urology and World Journal of Urology and a reviewer for numerous peer-reviewed journals. I am an active member of the American Association of Urology and the Society of Urologic Oncology (of which I am a former board member). I also hold an appointment as Professor in the Department of Urology at Weill Cornell Medical College and Adjunct Professor at SUNY Downstate Medical Center.
- Clinical Expertise: Testicular Cancer
- Languages Spoken: English
- Education: MD, University of Florida College of Medicine
- Residencies: Urology - University of Rochester Medical School
- Fellowships: Urologic Oncology - University of Rochester Medical School
- Board Certifications: Urology
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more